您好,欢迎访问三七文档
Chapter13AntineoplasticAgentsMalignanttumorisaseriousthreattohumanhealthandthefrequently-occurringdiseases,thehumandeathcausedbymalignanttumorsisthesecondplaceamongthedeathofalldisease.Therapy:SurgicaloperationRadiationtherapyChemicaltreatmentAntineoplasticagentsaimatanti-malignanttumor,alsoknownasanti-cancerdrugs.Classificationbymechanism•1.Alkylatingagents•2.Antimetabolites•3.Drugsinteferingwithsynthesisofproteinoftumorcells13.1Biologicalalkylatingagents•1.Nitrogenmustards•2.Ethyleneimines•3.Sulfonatesandhalogenatedpolyols•4.Nitrosourea•Bioalkylatingagentsarecytotoxicdrugs.Invivo,itisabletoformapositivechargedcarbon-ionorotheractiveelectrophilicgroups,andthentheelectrophilicionscombinecovalentlywithelectronrichgroups(suchasamino,sulfhydryl,hydroxyl,carboxyl,phosphate,etc.)ofthecellsofbiologicalmacromolecules(DNA,RNA,enzymes),leadtothebreakingofDNAmolecule,atlastresultinthedeathoftumor.•However,bioalkylatingdrugsalsoinhibitthenormalcellswiththepropertyofrapidproliferationsuchasbonemarrowcells,intestinalepithelialcellsatsametime.Sothebioalkylatingagentshavemoreserioussideeffects,suchasnausea,vomiting,bonemarrowsuppressionandhairloss.Clinicalusuallyarecarryingoncombinedusewithotherdrugs.BiologicalalkylatingagentsGeneralformulaofnitrogenmustardsNCH2CH2ClCH2CH2ClR载体部分烷基化部分(1)Fractionofalkylationisanti-tumorfunctiongroup,existingasbis-β-chloro-ethylamine.(2)Fractionofcarrier:可以改善药物药代动力学性质,选用不同载体,可提高选择性和抗肿瘤活性。依据载体化学结构,可分为脂肪氮芥、芳香氮芥、氨基酸氮芥、杂环氮芥和甾体氮芥。13.1.1NitrogenmustardsMechlorethaminehydrochlorideN-甲基-N-(2-氯乙基)-2-氯乙胺盐酸盐N-methyl-N-(2-chloroethyl)-2-chloroethylaminehydrochlorideClinicalapplication:mainlytreatmentforlymphosarcomaandHodgkin'sdiseaseDevelopment:duringtheFirstWorldWar,nitrogenmustardwasusedasatoxicgas,shortlyafteritwasfoundthepropertyofinhibitingbonemarrowandlymphoidtissueofthevictims.In1942,GilmanfromYaleUniversityfirstlyusednitrogenmustardinthetreatmentoflymphoidneoplasms.NCH3ClClHClNRClClSClCl芥子气烷基化部分载体部分DifferentR:脂肪氮芥、芳香氮芥Alkylationprocess:NRClCl-ClNRClXNRClX-ClNRXYNRYX乙撑亚胺离子脂肪氮芥的氮原子碱性比较强,烷基化历程是双分子亲核取代反应,活泼的乙撑亚胺离子极易与细胞成分的亲核中心起烷化作用,属强烷化剂。Itisusuallyusedasinjectiondrugofaqueoussolution,whichpHvaluemaintainedat3.0~5.0.Stability:NCH3ClClH2OpH7NCH3OHOHChlormethinehydrochloridepresentedstrongdestructiontotumorcells,butwithpoorselectivityandlargetoxicity.OnlyEffectiveforlymphoma,sostructuralmodificationisnecessary.Nitromin:Reducedthepossibilityofformationofethyleneimineforthereducedelectroniccloudonnitrogen.Nitrominislesstoxicity,butalsothereducedanti-tumoractivity.NCH3ClClO2.Aromaticnitrogenmustards:Theintroductionofaromaticringledtoreductionofalkalescencebyreasonofconjugation,somechanismwaschanged,noformationofcyclicethyleneimineionbuttheformationofcarboncationintermediate.NArClCl-ClX-ClYNArClNArClXNArXNArYXHOOHOOCHNHRR=HR=CHO溶肉瘤素氮甲苯丁酸氮芥NClClNClClCyclophosphamide123456P-[N,N-双-(β-氯乙基)]-1-氧-3-氮-2-磷杂环己烷-P-氧化物一水合物。Withabroadspectrumofanti-tumor。Physicochemicalpropertiesofcyclophosphamide•Whitecrystalorcrystallinepowder(失去结晶水即液化)•Soluableinwater,unstableinaqueoussolutionandeasilyhydrolyze,easilydecomposeunderheatingcondition.•Cyclophosphamideisaprodrug.在肝脏被活化,经非酶促的β-消除反应生成丙烯醛(膀胱毒性)、磷酰氮芥及去甲氮芥,三者都是较强的烷化剂。POHNNO肝脏酶正常组织酶正常组织肿瘤细胞4-羟基环磷酰胺磷酰氮芥(ClCH2CH2)2POHNNO(ClCH2CH2)2OHPONH2NO(ClCH2CH2)2CHOPOHNNO(ClCH2CH2)2OPONH2NO(ClCH2CH2)2COOHPONH2NO(ClCH2CH2)2+CH2CHCHOHNClClCyclophosphamidehasabroadspectrumofanti-tumor,clinicalfortreatmentofmalignantlymphoma,acutelymphocyticleukemia,multiplemyeloma,lungcanceretc.ClinicalapplicationofcyclophosphamideNHHOCH2CH2HOCH2CH2NClCH2CH2ClCH2CH2CH2HOCH2NH2CH2PClClOHNPOONClCH2CH2ClCH2CH2HNPOONClCH2CH2ClCH2CH2H2O.POCl3C5H5NClCH2CH2ClH2OCH3COCH3以二乙醇胺作为原料,用过量的三氯氧磷同时进行氯代和磷酰化,制得氮芥磷酰二氯,再与3-氨基丙醇缩合。Synthesisofcyclophosphamide美法仑MelphalanNH2*CH2NCH2CH2ClCH2CH2ClCHCOOH氮芥类的烷化剂,结构包括氮芥和L-苯丙氨酸部分,氮芥部分在碱性水溶液中易水解,含有α-氨基酸结构,会发生茚三酮显色反应,且有氨基酸两性性质。•氮芥类药物是通过在体内转变成乙撑亚胺中间体发挥烷化剂作用,乙撑亚胺的磷酰胺衍生物,可提高抗肿瘤作用及减小毒性。•Tepawasclinicalusedfortreatmentofleukaemi。•Thiotepachangedintotepainvivo.Clinicalforthetreatmentofbreastcancer,ovariancancer,bladdercancer,andsoon.13.1.2EthyleneiminesTepaThiotepaSulfonatesandhalogenatedpolyolsarenon-nitrogenmustardalkylatingagents。甲磺酸酯是较好的离去基团,生成碳正离子与生物大分子发生亲核取代反应进行烷基化。Busulfan,alsoknownasMyleran,namedas:4-Butanedioldimethylsulfonate。Clinicalforthetreatmentofchronicmyeloidleukemia.多元醇类药物主要是卤代多元醇,进入体内后会形成双环氧化物而产生烷化作用。二溴甘露醇(Dibromomannitol)、二溴卫矛醇(Dibromodulcilol)等。13.1.3Sulfonatesandhalogenatedpolyols13.1.4NitrosoureasN-亚硝基的存在使该氮原子与邻近羰基之间的键变得不稳定,在体内分解生成亲电性基团,破坏DNA的结构。。Nitrosoureasarehighlylipophilic,easilypassthroughtheblood-brainbarrierfortreatmentofbraintumors,centralnervoussystemtumorsandmalignantlymphoma,butwithsideeffectsofdelayedbonemarrowsuppression.ClinicaluseddrugsincludesCarmustine(卡莫司汀),Lomostine(洛莫司汀),Semustine(司莫司汀),Nimustine(尼莫司汀)andsoon.卡莫司汀CarmustineClNHNOClNON,N’-双(β-氯乙基)-N-亚硝基脲,又名卡氮芥N,N'-bis-(β-chloroethyl)-N-nitrosoureaCarmustineishighlylipophilic,easilypassthroughtheblood-brainbarrierforthetreatmentofbraintumors,othercentralnervoussystemtumorsandmalignantlymphoma.NHOOHON
本文标题:第七章抗肿瘤药
链接地址:https://www.777doc.com/doc-369212 .html